Please check this out: Translating nanomedicines from the lab to the clinic
Author: Ruchi
Our recent publication on kidney targeting in Molecular Therapy covered in a special commentary
Our recently published manuscript in Molecular Therapy “Efficient and selective kidney targeting by chemically modified carbohydrate conjugates” got covered in a commentary “Not all carbs are bad for the kidney.” Please check this out.
Not all carbs are bad for the kidney: Molecular Therapy
Zeal Therapeutics, our lab startup, has been covered in media for our recent Molecular Therapy publication, “Efficient and Selective Kidney Targeting by Chemically Modified Carbohydrate Conjugates,” highlighting the innovative approaches behind our research.
Our recently published work in Molecular Therapy has been covered media news outlet.
Please check these out:
School of Pharmacy Startup Develops Promising Kidney-Targeting Drug Delivery System – UConn Today
Welcome Hamayal Sharma for joining our group from Fall 2024
We are excited to welcome our new lab member Hamayal Sharma to our lab. She is joining our lab as a Ph.D. graduate students.
Dr. Aniket Wahane successfully defended his PhD dissertation!
Congratulations to Dr. Aniket Wahane for defending his thesis. He did an excellent job and will join GenScript in Fall 2024. We wish him all the best!